New drug AMG 732 aims to reduce eye bulging in thyroid eye disease
NCT ID NCT06401044
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times
Summary
This study tests a new drug called AMG 732 for people with moderate-to-severe active thyroid eye disease, a condition that causes eye bulging and discomfort. The trial has two parts: Part A checks safety in healthy volunteers, and Part B tests how well the drug works in patients. Researchers will measure changes in eye protrusion and monitor for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AMG 732 (an injectable drug)
- What this could lead to
- If it works, this could lead to a new treatment option that reduces eye bulging and other symptoms of thyroid eye disease.
- What could go wrong
- This is an early-phase trial with only 88 participants, so results may not apply to everyone. The drug may cause side effects or fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aichi Medical University Hospital
Nagakute-shi, Aichi-ken, 480-1195, Japan
-
Amy Patel Jain MD
Newport Beach, California, 92660, United States
-
Applied Research Center of Arkansas
Little Rock, Arkansas, 72205, United States
-
Azienda Ospedaliero Universitaria Pisana
Pisa, 56124, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, 56126, Italy
-
Azienda Socio Sanitaria Territoriale dei Sette Laghi
Varese, 21100, Italy
-
Baylor College of Medicine Medical Center
Houston, Texas, 77030, United States
-
Buergerhospital und Clementine Kinderhospital gGmbH
Frankfurt am Main, 60318, Germany
-
CHU de Québec-Université Laval - CUO-Recherche Clinique, Hopital du Saint-Sacrement
Québec, Quebec, G1S 4L8, Canada
-
Centre Hospitalier Universitaire de Nantes - Hopital Nord Laennec
Nantes, 44800, France
-
Consano Clinical Research, LLC
Shavano Park, Texas, 78231, United States
-
Dc-Med Spolka z Ograniczona Odpowiedzialnoscia Spolka Komandytowa
Swidnica, 58-100, Poland
-
Eb Group Spolka z ograniczona odpowiedzialnoscia
Warsaw, 00-189, Poland
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
-
General Hospital of Athens Laiko
Athens, 11527, Greece
-
Hayashi Eye Hospital
Fukuoka, Fukuoka, 812-0011, Japan
-
Hopital Pitie-Salpetriere
Paris, 75013, France
-
Hospital Universitari i Politecnic La Fe
Valencia, 46026, Spain
-
Hospital Universitario Ramon y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen Macarena
Seville, Andalusia, 41009, Spain
-
Ilumina Medical Research
Kissimmee, Florida, 34744, United States
-
Ippokratio General Hospital of Thessaloniki
Thessaloniki, 54642, Greece
-
Kozawa Eye Hospital And Diabetes Center
Mito, Ibaraki, 310-0845, Japan
-
Levenson Eye Associates
Jacksonville, Florida, 32204, United States
-
Macquarie University
North Ryde, New South Wales, 2109, Australia
-
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, 02114, United States
-
National Taiwan University Hospital
Taipei, 10002, Taiwan
-
National University Hospital
Singapore, 119074, Singapore
-
North Shore Private Hospital
St Leonards, New South Wales, 2065, Australia
-
Ppd Las Vegas Research Unit
Las Vegas, Nevada, 89113, United States
-
Profesorskie Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia
Gdansk, 80-180, Poland
-
Santé Québec Est-de-l'Île-de-Montréal - Universitaire
Montreal, Quebec, H1T 2M4, Canada
-
Sarasota Retina Institute
Sarasota, Florida, 34239, United States
-
Singapore National Eye Centre
Singapore, 169608, Singapore
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
-
Universitaetsklinikum Essen
Essen, 45147, Germany
-
Universitaetsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
-
Universitaetsklinikum Leipzig AoeR
Leipzig, 04013, Germany
-
University of Miyazaki Hospital
Miyazaki, Miyazaki, 889-1692, Japan
-
Uniwersyteckie Centrum Stomatologii I Medycyny Specjalistycznej Spzoo
Poznan, 60-354, Poland
-
Vancouver General Hospital
Vancouver, British Columbia, V5Z 0A6, Canada
-
Vision Medical Research, Inc.
Orland Park, Illinois, 60462, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted antibody calm thyroid eye disease?
- Could a cholesterol drug shrink eye muscle swelling in thyroid eye disease?
- Can an experimental drug reduce eye bulging in thyroid eye disease?
- Can a new drug ease bulging eyes in thyroid disease?
- New drug IBI3031 enters first human trial for thyroid eye disease
- New hope for thyroid eye disease: drug shows promise in Steroid-Resistant patients